Parents, physicians and the public attempting to make sense of the controversy about antidepressants are torn between unproven claims and counter-claims about the drugs’ benefits and risks.
Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug
An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials.
Brain Images–What Do They Mean?
Benedict Carey of The New York Times reports with a degree of healthy skepticism about the latest scientific hoopla: Neuroscientists’ infatuation with brain imaging techniques.
When Trust in Doctors Erodes
"Soon, intuition and the personal experience of friends and family may seem as trustworthy as advice from a doctor in diagnosing an illness or judging a treatment."
Polypharm & New Antipsychotics Not More Beneficial-Just More Expensive
"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost."
Antipsychotic Drugs are Killing patients_Brit J Psychiatry
A major 17-year follow up study published in the British Journal of Psychiatry [1] found a 2.84 times (95% CI 2.06–3.90) increased risk of mortality in people with schizophrenia compared to those not so diagnosed, and with each addition of a neuroleptic (antipsychotic) drug, the risk increased another 2.50.
State Laws to Force Drugs on Mental Paitients Sparks Growing Debate_WSJ
"Mr. Stanley says he has donated nearly $300 million — including about $35 million in 2005 — to Dr. Torrey’s efforts, the bulk of it for research at universities and start-up drug companies."